950160.KQ
Price:
$20750
Market Cap:
$1.76T
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Industry
Biotechnology
IPO Date
2017-11-06
Stock Exchange
KOE
Ticker
950160.KQ
According to Kolon TissueGene, Inc.’s latest financial reports and current stock price. The company's current ROE is -125.48%. This represents a change of 97.40% compared to the average of -63.57% of the last 4 quarters.
The mean historical ROE of Kolon TissueGene, Inc. over the last ten years is -79.84%. The current -125.48% ROE has changed 57.15% with respect to the historical average. Over the past ten years (40 quarters), 950160.KQ's ROE was at its highest in in the June 2026 quarter at 24.50%. The ROE was at its lowest in in the December 2022 quarter at -149197.99%.
Average
-79.84%
Median
-23.17%
Minimum
-299.15%
Maximum
0%
Discovering the peaks and valleys of Kolon TissueGene, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.19%
Maximum Annual ROE = 0%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -299.15%
| Year | ROE | Change |
|---|---|---|
| 2025 | -299.15% | 1.19% |
| 2024 | -23.17% | 54.61% |
| 2023 | -14.98% | 23.09% |
| 2022 | -12.17% | -90.07% |
| 2021 | -122.57% | 41.10% |
| 2020 | -86.86% | -Infinity% |
The current ROE of Kolon TissueGene, Inc. (950160.KQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-112.43%
5-year avg
-94.41%
10-year avg
-79.84%
Kolon TissueGene, Inc.’s ROE is greater than SK bioscience Co.,Ltd. (-4.45%), less than Hugel, Inc. (16.14%), greater than Voronoi, Inc. (-93.63%), greater than HLB Co., Ltd. (-54.93%), greater than D&D Pharmatech (-23.74%), greater than LigaChem Biosciences Inc. (-37.15%), less than PharmaResearch Co., Ltd. (26.52%), greater than OliX Pharmaceuticals,Inc (-8.34%), greater than GI Innovation, Inc. (-35.74%), less than Chabiotech Co.,Ltd. (3.61%),
| Company | ROE | Market cap |
|---|---|---|
| -4.45% | $2.86T | |
| 16.14% | $2.65T | |
| -93.63% | $2.79T | |
| -54.93% | $5.14T | |
| -23.74% | $2.33T | |
| -37.15% | $3.64T | |
| 26.52% | $4.16T | |
| -8.34% | $1.99T | |
| -35.74% | $490.06B | |
| 3.61% | $760.37B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kolon TissueGene, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kolon TissueGene, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Kolon TissueGene, Inc.'s ROE?
How is the ROE calculated for Kolon TissueGene, Inc. (950160.KQ)?
What is the highest ROE for Kolon TissueGene, Inc. (950160.KQ)?
What is the 3-year average ROE for Kolon TissueGene, Inc. (950160.KQ)?
What is the 5-year average ROE for Kolon TissueGene, Inc. (950160.KQ)?
How does the current ROE for Kolon TissueGene, Inc. (950160.KQ) compare to its historical average?